Spotlight
Clinical
Events
CME
Partners
Subscribe
- COVID-19
- Biosimilars
- Cataract Therapeutics
- DME
- Gene Therapy
- Workplace
- Ptosis
- Optic Relief
- Imaging
- Geographic Atrophy
- AMD
- Presbyopia
- Ocular Surface Disease
- Practice Management
- Pediatrics
- Surgery
- Therapeutics
- Optometry
- Retina
- Cataract
- Pharmacy
- IOL
- Dry Eye
- Understanding Antibiotic Resistance
- Refractive
- Cornea
- Glaucoma
- OCT
- Ocular Allergy
- Clinical Diagnosis
- Technology
Advanced Solutions for Retinal Vascular Diseases: Achieving Superior Outcomes with Durable Treatments : Episode 3
Treating a DME Patient Lost to Follow-Up with a Highly Durable Agent
Katherine Talcott, MD, presents the case of a patient with diabetic macular edema, and the rest of the panel share their clinical experiences and discuss factors that inform the utilization of more durable agents.
EP: 1.A Case of Neovascular AMD With Treatment-Resistant Pigment Epithelium Detachment
EP: 2.A Case of Neovascular AMD with Persistent Subretinal Fluid
Now Viewing
EP: 3.Treating a DME Patient Lost to Follow-Up with a Highly Durable Agent
EP: 4.A Case of a DME Patient Achieving Extended Treatment Interval with New Therapy
EP: 5.Evolving Role of Steroids and Laser In DME
EP: 6.Impact Of Durable Agents on Treatment Burden and Quality of Life in Retinal Diseases
Related Videos
Related Content
